Toida M, Okumura Y, Swe Win K K, Oka N, Takami T, Adány R
Department of Oral Surgery and Oral Medicine, Ibi General Hospital, Japan.
Histochem J. 1995 Jun;27(6):449-56.
In the present study, the distribution pattern and characteristics of cells containing Factor XIII subunit a (FXIII A) have been studied in benign and malignant lesions of human buccal mucosa. Tissues from four irritation fibromas and three squamous cell carcinomas were studied by means of double immunofluorescent staining techniques in which the detection of FXIII A was combined with a reaction with CD14 (recognizing a monocyte/macrophage differentiation marker antigen), Mac 387 (reacting with a special subset of macrophages), anti-HLA-DR, Ki-M7 (labelling phagocytosing macrophages) or Ki-67 (visualizing a nuclear antigen associated with cell proliferation) monoclonal antibodies. FXIII A was detected in cells of the connective tissue stroma in both benign and malignant buccal lesions. The number of these FXIII A-reactive cells (FXIII A+ cells) increased considerably in the tumour tissues, in particular in those surrounding tumour cell clusters. FXIII A+ cells scattered in the fibromatous tissues were spindle-shaped, whereas in the tumour stroma, large stellate cells predominated, and round cells were likewise labelled around blood vessels. FXIII A+ cells were labelled with CD14 and Ki-M7 in both fibromatous and tumoural buccal mucosa; however, they failed to show any reaction with Ki-67. FXIII A+ cells accumulated in the tumour stroma reacted for HLA-DR as well. These results indicate that in both the benign and malignant buccal lesions FXIII A is contained in a subpopulation of tissue macrophages, which represents a monocyte-derived (CD14+) and phagocytosing (Ki-M7+) cell population. The accumulation of the FXIII A+ cells in the tumour stroma is believed to be a result of direct migration from the circulating blood.(ABSTRACT TRUNCATED AT 250 WORDS)
在本研究中,对人颊黏膜良性和恶性病变中含凝血因子 XIII a 亚基(FXIII A)的细胞的分布模式及特征进行了研究。采用双重免疫荧光染色技术对 4 个刺激性纤维瘤和 3 个鳞状细胞癌的组织进行研究,其中 FXIII A 的检测与 CD14(识别单核细胞/巨噬细胞分化标志物抗原)、Mac 387(与巨噬细胞的一个特殊亚群反应)、抗 HLA - DR、Ki - M7(标记吞噬性巨噬细胞)或 Ki - 67(显示与细胞增殖相关的核抗原)单克隆抗体的反应相结合。在颊部良性和恶性病变的结缔组织基质细胞中均检测到 FXIII A。这些 FXIII A 反应性细胞(FXIII A+细胞)的数量在肿瘤组织中显著增加,尤其是在肿瘤细胞簇周围的组织中。散在于纤维瘤组织中的 FXIII A+细胞呈梭形,而在肿瘤基质中,大的星状细胞占主导,血管周围的圆形细胞也被标记。在纤维瘤性和肿瘤性颊黏膜中,FXIII A+细胞均被 CD14 和 Ki - M7 标记;然而,它们与 Ki - 67 未显示任何反应。积聚在肿瘤基质中的 FXIII A+细胞也对 HLA - DR 有反应。这些结果表明,在颊部良性和恶性病变中,FXIII A 存在于组织巨噬细胞亚群中,该亚群代表单核细胞来源(CD14+)且具有吞噬功能(Ki - M7+)的细胞群体。FXIII A+细胞在肿瘤基质中的积聚被认为是循环血液直接迁移的结果。(摘要截于 250 字)